Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-19-026259
Filing Date
2019-12-16
Accepted
2019-12-16 16:26:29
Documents
59
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2019_citiuspharma.htm 10-K 754489
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM f10k2019ex23-1_citiuspharma.htm EX-23.1 3135
3 CERTIFICATION f10k2019ex31-1_citiuspharma.htm EX-31.1 13423
4 CERTIFICATION f10k2019ex31-2_citiuspharma.htm EX-31.2 14999
5 CERTIFICATION f10k2019ex32-1_citiuspharma.htm EX-32.1 5038
6 CERTIFICATION f10k2019ex32-2_citiuspharma.htm EX-32.2 5362
  Complete submission text file 0001213900-19-026259.txt   4166895

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE ctxr-20190930.xml EX-101.INS 545500
8 XBRL SCHEMA FILE ctxr-20190930.xsd EX-101.SCH 62761
9 XBRL CALCULATION FILE ctxr-20190930_cal.xml EX-101.CAL 45045
10 XBRL DEFINITION FILE ctxr-20190930_def.xml EX-101.DEF 198668
11 XBRL LABEL FILE ctxr-20190930_lab.xml EX-101.LAB 390797
12 XBRL PRESENTATION FILE ctxr-20190930_pre.xml EX-101.PRE 294875
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-38174 | Film No.: 191287420
SIC: 2834 Pharmaceutical Preparations